SOMRS
NBIX icon

State of Michigan Retirement System’s Neurocrine Biosciences NBIX Stock Holding History

State of Michigan Retirement System’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.96M Sell
23,481
-700
-3% -$104K 0.02% 510
2026
Q1 		$3.19M Buy
24,181
+600
+3% +$79.6K 0.02% 533
2025
Q4 		$3.34M Hold
23,581
– – 0.02% 520
2025
Q3 		$3.31M Sell
23,581
-200
-0.8% -$27.1K 0.02% 522
2025
Q2 		$2.99M Sell
23,781
-100
-0.4% -$11.5K 0.02% 532
2025
Q1 		$2.64M Sell
23,881
-100
-0.4% -$12.7K 0.02% 553
2024
Q4 		$3.27M Hold
23,981
– – 0.02% 513
2024
Q3 		$2.76M Sell
23,981
-300
-1% -$41.1K 0.01% 556
2024
Q2 		$3.34M Sell
24,281
-200
-0.8% -$27.4K 0.02% 498
2024
Q1 		$3.38M Buy
24,481
+900
+4% +$123K 0.02% 503
2023
Q4 		$3.11M Buy
23,581
+200
+0.9% +$23K 0.02% 504
2023
Q3 		$2.63M Sell
23,381
-700
-3% -$73.7K 0.02% 520
2023
Q2 		$2.27M Sell
24,081
-300
-1% -$29.3K 0.01% 567
2023
Q1 		$2.47M Sell
24,381
-100
-0.4% -$10.4K 0.02% 546
2022
Q4 		$2.92M Buy
24,481
+400
+2% +$46.9K 0.02% 501
2022
Q3 		$2.56M Sell
24,081
-200
-0.8% -$20.3K 0.02% 515
2022
Q2 		$2.37M Buy
24,281
+200
+0.8% +$18.5K 0.02% 535
2022
Q1 		$2.26M Buy
24,081
+81
+0.3% +$6.87K 0.01% 575
2021
Q4 		$2.04M Buy
24,000
+300
+1% +$27.6K 0.01% 631
2021
Q3 		$2.27M Sell
23,700
-100
-0.4% -$9.45K 0.01% 577
2021
Q2 		$2.32M Sell
23,800
-10,900
-31% -$1.04M 0.01% 594
2021
Q1 		$3.38M Buy
+34,700
New +$3.64M 0.02% 527

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State of Michigan Retirement System's NBIX Position: Q2 2026 in Review

State of Michigan Retirement System reduced its Neurocrine Biosciences (NBIX) stake by 2.9% in Q2 2026, selling an estimated $104K and leaving 23,481 shares worth $3.96M. The position accounts for 0.02% of the portfolio, ranked #510.

State of Michigan Retirement System first reported a position in NBIX in Q1 2021 and has held it in 22 quarters since. 781 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • State of Michigan Retirement System held 23,481 shares of Neurocrine Biosciences worth $3.96M as of Q2 2026.
  • State of Michigan Retirement System sold 700 Neurocrine Biosciences shares in Q2 2026, an estimated $104K.
  • Neurocrine Biosciences made up 0.02% of State of Michigan Retirement System's portfolio in Q2 2026, its #510 holding.
  • State of Michigan Retirement System first reported a position in Neurocrine Biosciences in Q1 2021 and has held it in 22 quarters since.
  • 781 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on State of Michigan Retirement System's 13F filing for Q2 2026, filed 30 Jul 2026.